Profile
VOR VRTX REGN SGEN ARGX ALNY
Company Name Vor Biopharma Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $82.53M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.16K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Dr. Robert Ang M.B.A., M.D., MBBS Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
VOR VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
VOR VRTX REGN SGEN ARGX ALNY
Last Close $0.16 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $1.81 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.16 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -91.16 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 0 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
VOR VRTX REGN SGEN ARGX ALNY
1 Month Return -72.32 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return -88.65 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return -83.3 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return -80.49 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return -85.59 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return -91.16 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VOR VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -435.2 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
VOR VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM - 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -81.82 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -119.69 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -97.51 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 100 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 96.48 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM - -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -313.1 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM - 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 1.22 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM - 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM - 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -1.42 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -1.43 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 131.38 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.23 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -313.1 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -0.83 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -0.46 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -0.46 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
VOR VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.11B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.12B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -1.7 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
VOR VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.05B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.1B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0.01B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.03B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.14B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
VOR VRTX REGN SGEN ARGX ALNY
Net Income $-0.12B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.1B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.16
ABCL AbCellera Biologics Inc. 2.01
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.49
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.02
ABSI Absci Corporation 2.8
ABUS Arbutus Biopharma Corporation 3.3
ABVC ABVC BioPharma, Inc. 1.32
ABVX Abivax SA American Depositary Shares 6.85
ACAD ACADIA Pharmaceuticals Inc. 16.93
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4784
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.43
ACIU AC Immune SA 1.66
ACLX Arcellx, Inc. 56.26
ETFs With Exposure to VOR
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00156 201.21
VTI Vanguard Total Stock Market Index Fund 0 278.25
IBB iShares Biotechnology ETF 0.01 119.18
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00015 123.5
IWN iShares Russell 2000 Value ETF 0.00393 149.11
BIB ProShares Ultra Nasdaq Biotechnology 0.01 41.24
VXF Vanguard Extended Market Index Fund 0 177.37
HDG ProShares Hedge Replication ETF 0.000314694 48.808
UWM ProShares Ultra Russell2000 0.000630567 33.03
VTHR Vanguard Russell 3000 Index Fund 0 249.73
IWC iShares Micro-Cap ETF 0.00721 114.31
URTY ProShares UltraPro Russell2000 0.000299367 32.68
VTWV Vanguard Russell 2000 Value Index Fund 0 131.4
VTWO Vanguard Russell 2000 Index Fund 0 81.32
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 94.59
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 94.58
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.01
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47
VBINX Vanguard Balanced Index Fund Investor Shares 0 47
RYLD Global X Russell 2000 Covered Call ETF 0 14.6
IBBQ Invesco Nasdaq Biotechnology ETF 0.03 19.86
DFAT Dimensional U.S. Targeted Value ETF 0.00001351 51.12
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000224 33.13
VTSAX Vanguard Total Stock Market Index Fund 0 135.4
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02 5.755
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VITSX Vanguard Total Stock Market Index Fund 0 135.42
DFSU Dimensional US Sustainability Core 1 ETF 0.000012 36.13
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000102858 95.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00196238 32.6
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
DCOR Dimensional ETF Trust 0.00001406 61.74
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 254.04
RSSL Global X Funds 0 79.11
RFLR Innovator ETFs Trust 0.01 24.07
Unlock